Skip to main content
. 2021 Jan 21;11:612304. doi: 10.3389/fneur.2020.612304

Figure 1.

Figure 1

Age at onset in MOG-abs-positive patients in Israel. % of MOG-abs-seropositive patients of those patients with demyelinating disease tested for MOG-abs.